INTERNATIONAL PATENT: INNOLAKE BIOPHARMA (HANGZHOU) CO., LTD., 英诺湖医药（杭州）有限公司 FILES APPLICATION FOR "ANTI-B7H3 ANTIBODY-ERIBULIN CONJUGATE AND USE THEREOF"

GENEVA, Oct. 13 -- INNOLAKE BIOPHARMA (HANGZHOU) CO., LTD. (Room 301, Building 24, Yinhai Sci-Tech Innovation Center, Xiasha Street, Qiantang DistrictHangzhou, Zhejiang 310018), 英诺湖医药（杭州）有限公司 (中国浙江省杭州市钱塘新区下沙街道银海科创中心24幢301室) filed a patent application (PCT/CN2025/085077) for "ANTI-B7H3 ANTIBODY-ERIBULIN CONJUGATE AND USE THEREOF" on Mar 26, 2025. With publication no. WO/2025/209279, the details related to the patent application was published on Oct 09, 2025.

Notably, the patent applicat...